InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (1 ops.)
Browse the complete record of transactions filed by FREDRIK BRAG, CEO et cofondateur de MEDIAN Technologies. Director active across 1 companies, notably Median Technologies. Aggregated, 9 filings have been published. Total volume traded: €2m. The latest transaction was filed on 5 August 2025 (Acquisition). Regulator: AMF. All data is accessible without signup.
Declarations9 total
€100,00060,241 shares@ €1.660.14% mcap3.4% of flow
ActionEuronext Growth Paris
2025DD1052971·
Ideal exit: 2 May 2026 (T+270)
028,000 shares0
ACTIONS GRATUITES AGAEuronext Growth Paris
2023DD939339·
Ideal exit: 20 Jul 2024 (T+270)
€12,8662,737 shares@ €4.70070.019% mcap100.0% of flow
ActionEuronext Growth Paris
2023DD930781·
Ideal exit: 23 Jun 2024 (T+270)
0200,000 shares0
ACTIONS GRATUITES AGAEuronext Growth Paris
2022DD868306·
0200,000 shares0
ACTIONS GRATUITES AGAEuronext Growth Paris
2022DD872928·
€37,8073,104 shares@ €12.180.054% mcap52.5% of flow
ActionEuronext Growth Paris
2022DD830619·
Ideal exit: 11 Dec 2022 (T+270)
€34,2332,887 shares@ €11.85770.049% mcap47.5% of flow
ActionEuronext Growth Paris
2022DD825693·
Ideal exit: 22 Nov 2022 (T+270)
€2m111,111 shares@ €16.202.59% mcap62.1% of flow
ActionEuronext Growth Paris
2021DD811912·
€999,999111,111 shares@ €9.0034.5% of flow
ActionEuronext Growth Paris
2021DD771214·
9 of 9 declarations
About FREDRIK BRAG
Fredrik Brag is the co-founder and Chief Executive Officer of MEDIAN Technologies, a French company focused on medical imaging software and services for oncology, clinical trials, and cancer diagnosis. He founded the company in 2002 and has remained one of its central leaders ever since, combining entrepreneurial vision with deep experience in healthcare technology. Public sources indicate that he has also served as Chairman and CEO in the past, before continuing in a chief executive and board role, underscoring his long-standing strategic influence over the company’s direction. Before founding MEDIAN Technologies, Brag built expertise in business development, fundraising, and IPOs within technology companies. He also previously served at HealthCenter / Focus Imaging, where he gained practical experience in specialized medical imaging as well as information and communication technologies applied to healthcare. That background helped shape his profile as an operator who understands both the commercial and technical sides of building a health-tech business. At MEDIAN Technologies, Brag has helped develop an international platform serving pharmaceutical companies and healthcare stakeholders across Europe, North America, and Asia. Under his leadership, the company expanded its offering from phenomics imaging to broader imaging services for clinical drug development and cancer care. His tenure is associated with MEDIAN’s evolution into a publicly listed company, the strengthening of its global footprint, and its recent focus on AI-enabled tools for lung cancer screening and diagnostic support through the eyonis® program. A graduate of the Stockholm School of Economics, Fredrik Brag is widely positioned as a deep-tech healthcare executive with a strong track record in innovation, capital formation, and long-term value creation. His career is closely linked to MEDIAN Technologies’ growth, internationalization, and strategic shift toward advanced imaging and AI-based cancer diagnostics.
